ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma

Zhao, Jianhui; Lin, Xi; Zhuang, Jinman; He, Fei*南方医科大学
Frontiers in Genetics2021-10-20DOI: 10.3389/fgene.2021.714697
15被引5阅读
引用收藏
分享

摘要

Background: Lung adenocarcinoma (LUAD) is the major subtype of lung cancer and is associated with very high mortality. Emerging studies have shown that N6-methyladenosine (m6A)-related long non-coding (lnc) RNAs play crucial roles in tumor prognosis and the tumor immune microenvironment (TME). We aimed to explore the expression patterns of different m6A-related lncRNAs concerning patient prognosis and construct an m6A-related lncRNA prognostic model for LUAD. @@@ Methods: The prognostic value of m6A-related lncRNAs was investigated in LUAD samples from The Cancer Genome Atlas (TCGA). Potential prognostic m6A-related lncRNAs were selected by Pearson's correlation and univariate Cox regression analysis. Patients were divided into clusters using principal component analysis and the m6A-related lncRNA prognostic signature was calculated using least absolute shrinkage and selection operator (LASSO) Cox regression analysis. @@@ Results: Based on 91 prognostic m6A-related lncRNAs, we identified two m6A-related-lncRNA pattern clusters with different overall survival (OS) and different TMEs. We subsequently verified our findings multidimensionally by constructing a 13 m6A-related lncRNA prognostic signature (m6A-LPS) to calculate the risk score, which was robust in different subgroups. The receiver operating characteristic (ROC) curves and concordance index demonstrated that m6A-LPS harbored a promising ability to predict OS in TCGA data set and independent GSE11969 cohort. The risk score was also related to OS, TME, and clinical stage, and the risk score calculated by our model was also identified as independent prognostic predictive factors for LUAD patients after adjustment for age, smoking, gender, and stage. Enrichment analysis indicated that malignancy and drug resistance-associated pathways were more common in cluster2 (LUAD-unfavorable m6A-LPS). Furthermore, the results indicated that the signaling pathway enriched by the target gene of 13 m6A-related lncRNAs may be associated with metastasis and progression of cancer according to current studies. @@@ Conclusion: The current results indicated that different m6A-related-lncRNA patterns could affect OS and TME in patients with LUAD, and the prognostic signature based on 13 m6A-related lncRNAs may help to predict the prognosis in LUAD patients.

学科与关键词

关键词
lung adenocarcinomaN6-methylandenosinelong non-coding RNAprognosistumor immune microenvironment
相关
加载中…
  • A Novel m6A-Related LncRNA Signature for Predicting Prognosis, Chemotherapy and Immunotherapy Response in Patients with Lung Adenocarcinoma
    Shen, Yefeng; Wang, Shaochun; Wu, Yuanzhou*Cells, 2022, 11(15): 2399.被引 5
  • N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients
    Zhang, Peiling; Liu, Guolong*; Lu, Lin*Frontiers in Cell and Developmental Biology, 2021, 9: 703629.被引 12
  • N6-Methyladenosine (m6A)-Related lncRNAs Are Potential Signatures for Predicting Prognosis and Immune Response in Lung Squamous Cell Carcinoma
    Zhou, Yang; Guan, Xuhui; Wang, Shuncong; Sun, Huanhuan*; Ma, Haiqing*Journal of Oncology, 2022, 2022: 5240611.
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Genetics
发表日期
2021-10-20
卷期
第 12 卷
页码
714697
DOI
10.3389/fgene.2021.714697
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
Fujian Provincial Health Research Talents Training Programme Medical Innovation Project [2019-CX-33]; Joint Funds for the innovation of science and Technology, Fujian province [2019Y9022]

作者

  • Z

    Zhao, Jianhui (第一作者)

    southern med univ

  • L

    Lin, Xi

    southern med univ

查看全部 4 位作者收起作者
  • Z

    Zhuang, Jinman

    fujian med univ

  • H

    He, Fei (通讯)

    fujian med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417